Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Pediatric Immunology · Agammaglobulinemia 7

Building Your Care Team: Specialists and the First Visit

At a Glance

Children with Agammaglobulinemia 7 need coordinated lifelong care led by a pediatric immunologist, with genetics and lung specialists as needed. Bring infection, laboratory, genetic, vaccine, and infusion records to the first visit.

Managing a rare diagnosis like Agammaglobulinemia 7 (AGM7) requires more than just one doctor; it takes a dedicated team of specialists who understand how to protect a child with a profound antibody deficiency [1][2]. Because AGM7 is a lifelong condition, your goal is to build a “medical home” where your child’s health is monitored by experts who communicate with each other [3][4].

Your Core Medical Team

While your pediatrician remains your child’s primary doctor for general health, they will now be supported by a group of specialists:

  • Pediatric Immunologist: This is the most important member of your team [3]. They will oversee your child’s immunoglobulin replacement therapy (IRT), monitor B-cell counts, and manage your child’s overall immune health [2].
  • Clinical Geneticist: Since AGM7 is a genetic condition caused by SLC39A7 variants, a genetic counselor or geneticist helps confirm the diagnosis [5][6]. They can explain the inheritance pattern and help determine if siblings or other family members should be tested [7][8].
  • Pediatric Pulmonologist: Because the lungs are vulnerable to damage from repeated infections, a lung specialist is often involved. They monitor for signs of bronchiectasis (lung scarring) and ensure your child’s breathing remains healthy [9][10].
  • Specialized Nursing & Social Support: You will likely work with an immunology nurse who can teach you home infusions, a specialty pharmacist for antibody supply, and social workers who can assist with insurance coverage, school accommodations, and psychosocial support [11][12].

Preparing for Your First Appointment

The first visit with a specialist is an opportunity to provide them with the “evidence” they need to tailor your child’s care. To make the most of this visit, bring a binder or folder containing:

  1. Infection History: A detailed timeline of every infection your child has had, including dates, symptoms, and which antibiotics were used [13][14].
  2. Laboratory Reports: Hard copies of the flow cytometry (B-cell counts) and quantitative immunoglobulin (antibody levels) tests [15][16].
  3. Genetic Test Results: The full report for the SLC39A7 gene sequencing [17].
  4. Vaccination Records: Bring a list of all vaccines your child has received. Note: Do not worry about measuring vaccine “titers” (antibody levels) yourself. Because IVIG/SCIG supplies donor antibodies, serologic tests are very difficult to interpret and may not represent your child’s own response. Bring the date, product, and dose of their last infusion instead [16][18].
  5. Microbiology Results: Any “cultures” or PCR tests that identified a specific bacteria or virus during a past illness [19][20].

Identifying a High-Quality Clinic

Not all clinics have the same experience with rare B-cell disorders. When choosing where your child will receive care, prioritize centers that offer:

  • PID Expertise: Ask the doctor: “How do you distinguish AGM7 from other causes of agammaglobulinemia, and how many patients with primary immunodeficiencies do you follow?” [21][22].
  • Coordinated Care & 24/7 Access: A top-tier center will have a structured way for the immunologist to collaborate with other specialists, and will offer reliable after-hours access for infection advice [1][23].
  • Research & Advocacy Connections: Many leading centers participate in observational registries (like USIDNET or the ESID registry) or connect families with advocacy organizations (like the Immune Deficiency Foundation). While registry participation is entirely optional, it often indicates a clinic is engaged with the latest rare-disease research [24][25].

Common questions in this guide

What specialists should care for a child with AGM7?
A pediatric immunologist usually coordinates care and manages immunoglobulin replacement. A clinical geneticist or genetic counselor can address the SLC39A7-related diagnosis and family testing, while a pediatric pulmonologist monitors lung health; the pediatrician and support staff help with general care and practical needs.
What should I bring to my child’s first AGM7 appointment?
Bring an infection timeline, reports showing B-cell counts and antibody levels, the complete SLC39A7 genetic report, vaccination records, and any culture or PCR results. Also record the date, product, and dose of the child’s most recent IVIG or SCIG infusion.
Why are vaccine antibody tests hard to interpret during IVIG or SCIG?
IVIG and SCIG contain antibodies donated by other people, so blood tests for vaccine antibodies may reflect the infused product rather than your child’s own immune response. Bring the infusion date, product, and dose instead, and let the immunology team decide which tests are useful.
How can I choose a clinic experienced in AGM7?
Look for a center with primary immunodeficiency expertise, coordinated access to immunology and other specialists, and reliable after-hours advice for infections. You can ask how many children with immune deficiency disorders the clinic follows and how it distinguishes AGM7 from other causes of very low antibody levels.
What practical help is available for managing immunoglobulin therapy?
An immunology nurse may teach home infusions, a specialty pharmacist may help coordinate antibody supplies, and a social worker may assist with insurance, school accommodations, and emotional support. Ask whether the clinic can help with coverage approvals or financial assistance.
How can genetic counseling help a family affected by AGM7?
A geneticist or counselor can explain that AGM7 is inherited through SLC39A7 variants and discuss whether siblings or other relatives should be offered testing. They can help your family understand the results and coordinate appropriate follow-up.

Get notified when new evidence is published on agammaglobulinemia 7, autosomal recessive.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (25)
  1. 1

    Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.

    Cornelissen HM, Glanzmann B, Van Coller A, et al.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2021; (111(10)):998-1005 doi:10.7196/SAMJ.2021.v111i10.15341.

    PMID: 34949297
  2. 2

    Multidisciplinary approach to early identification of inborn errors of immunity in patients with lymphoproliferation.

    Alsina L, Celis Passini V, Garrido Colino C, et al.

    Leukemia & lymphoma 2026; (67(11)):2192-2205 doi:10.1080/10428194.2026.2704265.

    PMID: 42518275
  3. 3

    Immunoglobulin disorders in pediatric chronic rhinosinusitis.

    Lewandrowski C, Peppers BP, Makary CA

    Current opinion in allergy and clinical immunology 2026; (26(1)):1-6 doi:10.1097/ACI.0000000000001135.

    PMID: 41451820
  4. 4

    Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management.

    Pashangzadeh S, Yazdani R, Nazari F, et al.

    Endocrine, metabolic & immune disorders drug targets 2020; (20(9)):1434-1447 doi:10.2174/1871530320666200508114349.

    PMID: 32384040
  5. 5

    Next-generation sequencing for inborn errors of immunity.

    Lee K, Abraham RS

    Human immunology 2021; (82(11)):871-882 doi:10.1016/j.humimm.2021.02.011.

    PMID: 33715910
  6. 6

    Clinical Utility of Whole Exome Sequencing and Targeted Panels for the Identification of Inborn Errors of Immunity in a Resource-Constrained Setting.

    Engelbrecht C, Urban M, Schoeman M, et al.

    Frontiers in immunology 2021; (12()):665621 doi:10.3389/fimmu.2021.665621.

    PMID: 34093558
  7. 7

    Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.

    Chear CT, Ismail IH, Chan KC, et al.

    Frontiers in immunology 2023; (14()):1252765 doi:10.3389/fimmu.2023.1252765.

    PMID: 37809070
  8. 8

    Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis.

    Blom M, Duintjer AJ, Jamee M, et al.

    Journal of clinical immunology 2025; (45(1)):125.

    PMID: 40853601
  9. 9

    Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.

    Fekrvand S, Yazdani R, Olbrich P, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.

    PMID: 32058651
  10. 10

    Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency.

    Smits BM, Boland SL, Hol ME, et al.

    The journal of allergy and clinical immunology. In practice 2024; (12(4)):1037-1048.e3 doi:10.1016/j.jaip.2023.12.047.

    PMID: 38182096
  11. 11

    Infusion parameters, safety, and practical guidance for the manual administration of subcutaneous immunoglobulin 20% (Ig20Gly).

    Grosse-Kreul D, Allen C, Kalicinsky C, Keith PK

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2024; (20(1)):52 doi:10.1186/s13223-024-00914-7.

    PMID: 39367472
  12. 12

    Infection prevention in patients with inborn errors of immunity: Insights from Japan's nationwide study.

    Yao Z, Kido T, Hosaka S, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2025; (67(1)):e70093 doi:10.1111/ped.70093.

    PMID: 40791179
  13. 13

    X-linked agammaglobulinemia: ınvestigation of clinical and laboratory findings, novel gene mutations and prevention of ınfective complications in long-term follow-up.

    Yıldırım İ, Topyıldız E, Bilgin RBG, et al.

    American journal of clinical and experimental immunology 2021; (10(1)):37-43.

    PMID: 33815962
  14. 14

    A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.

    Hernandez-Trujillo V, Zhou C, Scalchunes C, et al.

    Journal of clinical immunology 2023; (43(6)):1468-1477 doi:10.1007/s10875-023-01502-x.

    PMID: 37219739
  15. 15

    Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.

    Yeh YH, Hsieh MY, Lee WI, et al.

    Frontiers in immunology 2020; (11()):2001 doi:10.3389/fimmu.2020.02001.

    PMID: 33013854
  16. 16

    X-linked Agammaglobulinemia With Normal Immunoglobulin and Near-Normal Vaccine Seroconversion.

    Preece K, Lear G

    Pediatrics 2015; (136(6)):e1621-4 doi:10.1542/peds.2014-3907.

    PMID: 26527549
  17. 17

    Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity.

    Giardino G, Di Matteo G, Giliani S, et al.

    The Journal of allergy and clinical immunology 2025; (155(4)):1149-1160 doi:10.1016/j.jaci.2024.11.030.

    PMID: 39622296
  18. 18

    [Sepsis due to Pseudomona as a debut of a primary immunodeficiency in a child].

    Vera Sáez-Benito MC, López Úbeda M, Madurga Revilla P, et al.

    Archivos argentinos de pediatria 2016; (114(6)):e444-e447 doi:10.5546/aap.2016.e444.

    PMID: 27869430
  19. 19

    Clinical and genetic characterization of X-linked agammaglobulinemia in a Colombian cohort.

    Olaya Hernández M, Triviño Arias J, Arias Valderrama O, et al.

    The World Allergy Organization journal 2026; (19(9)):101441 doi:10.1016/j.waojou.2026.101441.

    PMID: 42733469
  20. 20

    X-Linked Agammaglobulinemia Presenting as Neutropenia: Case Report and an Overview of Literature.

    Lanlokun M, Borden A, Nieves D, et al.

    Frontiers in pediatrics 2021; (9()):633692 doi:10.3389/fped.2021.633692.

    PMID: 34262886
  21. 21

    An essential role for the Zn2+ transporter ZIP7 in B cell development.

    Anzilotti C, Swan DJ, Boisson B, et al.

    Nature immunology 2019; (20(3)):350-361 doi:10.1038/s41590-018-0295-8.

    PMID: 30718914
  22. 22

    A Novel BLNK Gene Mutation in a Four-Year-Old Child Who Presented with Late Onset of Severe Infections and High IgM Levels and Diagnosed and Followed as X-Linked Agammaglobulinemia for Two Years.

    Topyildiz E, Edeer Karaca N, Aygun A, et al.

    Case reports in immunology 2022; (2022()):7313009 doi:10.1155/2022/7313009.

    PMID: 35719418
  23. 23

    Syndromic immunodeficiencies: a pediatrician's perspective on selected diseases.

    Szczawinska-Poplonyk A, Begier K, Dorota A, et al.

    Allergologia et immunopathologia 2021; (49(4)):117-136 doi:10.15586/aei.v49i4.200.

    PMID: 34224226
  24. 24

    Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients.

    Kindle G, Alligon M, Albert MH, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.02.20.25322586.

    PMID: 40568655
  25. 25

    Disparities in Diagnosis, Access to Specialist Care and Treatment for Inborn Errors of Immunity.

    Lawrence MG, Rider NL, Cunningham-Rundles C, Poli MC

    The journal of allergy and clinical immunology. In practice 2023; doi:10.1016/j.jaip.2023.10.041.

    PMID: 39492552

This page is for informational purposes only and does not constitute medical advice. Your child’s immunologist, pediatrician, and other specialists should interpret the diagnosis, tests, and treatment plan for your child.

Guide contents agammaglobulinemia 7, autosomal recessive
Research & Literature
04 Living with Protection 06 Living with AGM7